NCT06674772Recruiting
Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
Fenotipado Molecular De Pacientes Con Migraña Según Edad Y Sexo a Través De La Cuantificación De CGRP En Saliva Para Realizar Medicina De Precisión: Estudio FAST
Source: ClinicalTrials.gov · Last updated 13 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Patients will be asked to visit the study center 2 times, the first time for clinical assessment and a second time for sample collection. Healthy controls will only be asked to visit the study center for sample collection. A sample of blood and saliva will be collected in order to measure CGRP levels and DNA and hormone testing.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 440 (estimated)
- First submitted
- 24 Oct 2024
- Start date
- 29 Nov 2022
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Diseases
- Migraine
- NCT number
- NCT06674772
What you commit to
- Study type: Observational
- Planned participants: 440
- From 29 Nov 2022 to the primary completion date, 30 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Abuse or dependence to tobacco, alcohol or any drug in the previous 12 months before the enrollment.
Other illness
- Presence of any major medical or neurological illness.
Other
- Presence of any salivary gland malfunction.
- Active migraine preventive treatment.
- Pregnant or breastfeeding female.
Who the study is looking for
- Migraine patients according to ICHD-3 criteria
- Healthy controls paired to patient age and sex, without headache and without first degree family history of headache.
Age in the registry: 6 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vall d'Hebron University Hospital Coordinator of this site? Confirm its status | Barcelona | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.